The revenue stands at ₹2,604.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 4.09 per cent from ₹2,715.00 crore. This corresponds to a year-on-year *(YoY) growth of 12.29 per cent.
Operating Profit stands at ₹816.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.11 per cent from ₹888.00 crore. This corresponds to a year-on-year *(YoY) growth of 9.83 per cent.
PBDT stands at ₹898.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 12.39 per cent from ₹1,025.00 crore. This corresponds to a year-on-year *(YoY) growth of 8.85 per cent.
Profit Before Tax stands at ₹780.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 14.47 per cent from ₹912.00 crore. This corresponds to a year-on-year *(YoY) growth of 7.44 per cent.
Net Profit stands at ₹583.00 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 15.38 per cent from ₹689.00 crore. This represents a 1.02 per cent year-on-year *(YoY) decline for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Divi's Lab. | -1.36% | -1.02% | 9.31% | 7.59% | 0.73% | 9.34% |
| Sun Pharma.Inds. | -1.42% | -0.24% | 11.74% | 8.70% | 6.34% | 8.56% |
| Torrent Pharma. | -2.93% | 0.52% | 4.81% | 7.51% | 14.50% | 35.51% |
| Dr Reddy's Labs | -0.94% | -3.08% | 2.83% | 0.20% | 2.88% | 5.25% |
| Cipla | -0.73% | -5.13% | 6.92% | -2.68% | -15.12% | -14.76% |
Chairman & Managing Director : Murali K Divi
Executive Director : N V Ramana
Whole Time Director & Chief Executive Officer : Kiran S Divi
Chairman & Independent Director : Ramesh B V Nimmagadda
Whole Time Director- Commercial : Nilima Prasad Divi
Independent Director : S Ganapaty
Independent Director : Sunaina Singh
Independent Director : Kosaraju Veerayya Chowdary
Company Sec. & Compli. Officer : Satish Choudhury
Director (Manufacturing) : S. Devendra Rao
Independent Director : Rajendrakumar Premchand Shah